Meera Agar

Prof. Meera Agar


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
MAMeera Agar
Meera Agar
PLPeter G. Lawlor
Peter G. Lawlor
Steve QuinnSteve Quinn
Steve Quinn
BDBrian Draper
Brian Draper
GCGideon A. Caplan
Gideon A. Caplan
DCDavid C Currow
David C Currow
Delirium is highly prevalent in patients receiving palliative care, with up to 4 in 10 people having delirium on admission to a palliative care unit, and higher rates seen at the end of life.1 Symptom relief is important to reduce the known distress associated with delirium; thus, effective, evidence-based management strategies that optimally balance benefits and risks are needed.2

26 March 2014 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
TLTim Luckett
Tim Luckett
JPJane Louise Phillips
Jane Louise Phillips
MAMeera Agar
Meera Agar
CVClaudia Virdun
Claudia Virdun
AGAnna Green
Anna Green
Patricia Mary DavidsonPatricia Mary Davidson
Patricia Mary Davidson
Population ageing, changes to the profiles of life-limiting illnesses and evolving societal attitudes prompt a critical evaluation of models of palliative care. We set out to identify evidence-based models of palliative care to inform policy reform in Australia.

21 December 2019 in European Geriatric Medicine
Verified
Journal Article
Closed access
GCGideon A. Caplan
Gideon A. Caplan
ATAndrew Teodorczuk
Andrew Teodorczuk
JSJared Streatfeild
Jared Streatfeild
MAMeera Agar
Meera Agar

1 September 2024 in JCO Oncology Practice
Verified
Journal Article
Closed access
Nicolas H. HartNicolas H. Hart
Nicolas H. Hart
LNLarissa Nekhlyudov
Larissa Nekhlyudov
TSThomas J. Smith
Thomas J. Smith
JYJasmine Yee
Jasmine Yee
MFMargaret I Fitch
Margaret I Fitch
RCRaymond J. Chan
Raymond J. Chan
PURPOSE: People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared with those with early-stage disease or those nearing the end of life. These Multinational Association for Supportive Care in Cancer (MASCC)-ASCO standards and practice recommendations seek to establish consistent provision of quality survivorship care for people affected by advanced or metastatic cancer. METHODS: A MASCC-ASCO expert panel was formed. Standards and recommendations relevant to the provision of quality survivorship care for people affected by advanced or metastatic cancer were developed through conducting (1) a systematic review of unmet supportive care needs; (2) a scoping review of cancer survivorship, supportive care, and palliative care frameworks and guidelines; and (3) an international modified Delphi consensus process. RESULTS: A systematic review involving 81 studies and a scoping review of 17 guidelines and frameworks informed the initial standards and recommendations. Subsequently, 77 experts (including eight people with lived experience) across 33 countries (33% were low- to middle-resource countries) participated in the Delphi study and achieved ≥94.8% agreement for seven standards, (1) Person-Centered Care; (2) Coordinated and Integrated Care; (3) Evidence-Based and Comprehensive Care; (4) Evaluated and Communicated Care; (5) Accessible and Equitable Care; (6) Sustainable and Resourced Care; and (7) Research and Data-Driven Care, and ≥84.2% agreement across 45 practice recommendations. CONCLUSION: Standards of survivorship care for people affected by advanced or metastatic cancer are provided. These MASCC-ASCO standards support optimization of health outcomes and care experiences by providing guidance to stakeholders (health care professionals, leaders, and administrators; governments and health ministries; policymakers; advocacy agencies; cancer survivors and caregivers). Practice recommendations may be used to facilitate future research, practice, policy, and advocacy efforts. Additional information is available at www.mascc.org , www.asco.org/standards and www.asco.org/survivorship-guidelines .

9 September 2011 in Palliative Medicine
Verified
Journal Article
Closed access
MAMeera Agar
Meera Agar
BDB Draper
B Draper
PPPa Phillips
Pa Phillips
JPJane Louise Phillips
Jane Louise Phillips
ACA Collier
A Collier
DCD Currow
D Currow
Background: Delirium has a significant impact on nursing practice from diagnosis and management, with under-detection and variable management of delirium being international problems. This study aimed to explore nurses’ assessment and management of delirium when caring for people with cancer, the elderly or older people requiring psychiatric care in the inpatient setting. Methods: Participants in this qualitative study were nurses working in Australian public hospital inpatient dedicated units in palliative care, aged care (geriatrics), aged care (geriatric) psychiatry and oncology. Semi-structured interviews were used to explore nurses’ views about specific areas of delirium assessment and management. Purposive sampling was used and interviews conducted until thematic saturation reached. A thematic content analysis was performed from a grounded theory perspective. Results: A total of 40 participants were included in the study. The analysis revealed four broad analytical themes: (1) superficial recognition and understanding of the operational definition of delirium or recognition of delirium as a syndrome; (2) nursing assessment: investigative versus a problem solving approach; (3) management: maintaining dignity and minimizing chaos; and (4) distress and the effect on others. Discussion: Nurses have limited knowledge of the features of delirium regardless of their specialty discipline. Delirium was uniformly identified as a highly distressing experience for patients, families and staff alike. The majority of nurses had a superficial understanding of delirium management, and adopted a task-orientated approach aimed at addressing the more noticeable problems. These findings have implications for both education and knowledge translation. Innovative approaches are needed to align health professional behaviours with best evidence delirium care.

8 October 2021 in Current Oncology
Verified
Journal Article
Open access
PDF file
GTGina Tuch
Gina Tuch
WSWee Kheng Soo
Wee Kheng Soo
KLKi-Yung Luo
Ki-Yung Luo
KFKinglsey Frearson
Kinglsey Frearson
EOEk Leone Oh
Ek Leone Oh
HLHeather Lane
Heather Lane
Cognitive assessment is a cornerstone of geriatric care. Cognitive impairment has the potential to significantly impact multiple phases of a person’s cancer care experience. Accurately identifying this vulnerability is a challenge for many cancer care clinicians, thus the use of validated cognitive assessment tools are recommended. As international cancer guidelines for older adults recommend Geriatric Assessment (GA) which includes an evaluation of cognition, clinicians need to be familiar with the overall interpretation of the commonly used cognitive assessment tools. This rapid review investigated the cognitive assessment tools that were most frequently recommended by Geriatric Oncology guidelines: Blessed Orientation-Memory-Concentration test (BOMC), Clock Drawing Test (CDT), Mini-Cog, Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Short Portable Mental Status Questionnaire (SPMSQ). A detailed appraisal of the strengths and limitations of each tool was conducted, with a focus on practical aspects of implementing cognitive assessment tools into real-world clinical settings. Finally, recommendations on choosing an assessment tool and the additional considerations beyond screening are discussed.